FDA Adverse Event
Injury
Summary report: N
HEARTMATE II LVAS
MDR report key: 2770337
·
Received October 1, 2012
Report
- Report Number
- 2916596-2012-00925
- Event Type
- Injury
- Date Received
- October 1, 2012
- Date of Event
- September 3, 2012
- Report Date
- September 3, 2012
- Manufacturer
- THORATEC CORPORATION
- Product Code
- DSQ
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- CA, US
- Reporter Occupation
- HEALTH PROFESSIONAL
Narratives
Additional Manufacturer Narrative · 1
THE PT CONTINUES ON LVAD SUPPORT WITH NO FURTHER ISSUES REPORTED. NO FURTHER INFO IS AVAILABLE AT THIS TIME. A SUPPLEMENTAL REPORT WILL BE SUBMITTED WHEN THE MANUFACTURER'S INVESTIGATION IS COMPLETED.
Description of Event or Problem · 1
THE PT WAS IMPLANTED WITH A LEFT VENTRICULAR ASSIST DEVICE (LVAD). THE VAD COORDINATOR REPORTED THAT THE PT WAS EXPERIENCING POWER ELEVATIONS. THE PT WAS ADMITTED WITH ATRIAL FIBRILLATION AND WAS PLACED ON A HEPARIN DRIP DUE TO SUSPECTED HEMOLYSIS. THE VAD COORDINATOR ALSO REPORTED THAT THE STAFF NURSE SAW THE POWER GO UP WITH SUBSEQUENT FLOW +++. THE PT WAS GIVEN 500CC OF NORMAL SALINE AND PUMP PARAMETERS RETURNED TO NORMAL. THE PT WAS REPORTED TO BE ASYMPTOMATIC AND HEMODYNAMICS WERE WITHIN NORMAL LEVELS.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | HEARTMATE II LVAS | DSQ: LEFT VENTRICULAR ASSIST DEVICE | DSQ | THORATEC CORPORATION | 104911 | 109237 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Required Intervention |